Literature DB >> 20152087

Treatment of rhinosinusitis: the role of surgery.

A Cazzavillan1, R M Gaini, L Pignataro, E Piacentini, G Leo.   

Abstract

The treatment of rhinosinusitis in children is mostly medical. Surgery is indicated in few but important exceptions: orbital or intracranial complications of acute rhinosinusitis not responding to medical therapy, chronic rhinosinusitis (CRS) with persisting sinonasal infection and purulent discharge, cystic fibrosis, ciliary diskinesia, dacryocystitis due to sinusitis and resistant to medical treatment, fungal rhinosinusitis. According to recent data, 50 percent of ENT specialist perform an adenoidectomy to manage CRS before endoscopic sinus surgery (ESS). ESS techniques introduced in mid 90s, has significantly modified the treatment of complications of acute rhinosinusitis and of selected cases of chronic recurrent infections. ESS consists of minimally invasive surgical procedure as middle meatal antrostomy and anterior ethmoidectomy. Evidence suggests that adenoidectomy and ESS are the most frequent surgical procedure performed in RS management.

Entities:  

Mesh:

Year:  2010        PMID: 20152087

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  3 in total

1.  Modeling Chronic Dacryocystitis in Rabbits by Nasolacrimal Duct Obstruction with Self-Curing Resin.

Authors:  Kai Hou; Tao Ai; Rong Liu; Nan Xiang; Jing Jin; Weikun Hu; Ban Luo
Journal:  J Ophthalmol       Date:  2017-06-22       Impact factor: 1.909

2.  The development of optic neuropathy after chronic rhinosinusitis: A population-based cohort study.

Authors:  Chan-Wei Nien; Chia-Yi Lee; Pei-Hsuan Wu; Hung-Chi Chen; Jessie Chao-Yun Chi; Chi-Chin Sun; Jing-Yang Huang; Hung-Yu Lin; Shun-Fa Yang
Journal:  PLoS One       Date:  2019-08-07       Impact factor: 3.240

3.  The Development of Keratopathy after Surgery-Indicated Chronic Rhinosinusitis: A Population-Based Cohort Study.

Authors:  Hung-Jui Hsu; Chia-Yi Lee; Kun-Lin Yang; Hung-Chi Chen; Chi-Chin Sun; Jing-Yang Huang; Hung-Yu Lin; Shun-Fa Yang
Journal:  Int J Environ Res Public Health       Date:  2019-04-05       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.